CancerNetwork shared a post on X:
“Want to catch up on articles from SABCS?
Read our top 10 articles from the conference!”
-
- Neoadjuvant HER3-DXd Maintains Response Rates with Fewer TRAEs in Breast Cancer.
- Olaparib Yields Long-Term Efficacy in BRCA+ HER2-Negative Breast Cancer.
- Fam-Trastuzumab Deruxtecan-nxki Improves Efficacy in Metastatic Breast Cancer.
- Surgical Intervention Improves Efficacy in Young Patients with Breast Cancer.
- Specific Biomarkers Confer Higher pCR/EFS in Triple-Negative Breast Cancer.
- Immediate Surgery Lowers Local Recurrence in Older Breast Cancer Population.
- Real-World Data Show No OS Difference Among CDK4/6 Inhibitor Combos in HR+/HER2– MBC.
- Tamoxifen Shows Significant Reduction in Overall Recurrence in Breast Cancer.
- Active Monitoring Noninferior to Standard Surgery, RT in Low-risk DCIS.
- Exclusive Radiation Therapy Improves QOL and Safety Outcomes in Breast Cancer.
